Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2025-12-25 @ 3:52 AM
NCT ID: NCT05659602
Eligibility Criteria: Inclusion Criteria: * 18 to 65 years old. * Participants with mild COVID-19 with symptom onset≤5 days or asymptomatic COVID-19. * Participants being able and willing to provide informed consent prior to any study-specific procedure. Exclusion Criteria: * Participants with moderate or severe COVID-19. * Participants within the pregnancy or breastfeeding period or plan to be pregnant during the study period. * Participants requiring oxygen treatment (such as non-invasive ventilation, invasive mechanical ventilation, ECMO, etc.). * Participants with nasal disease that is inconvenient or intolerant of nasal spray administration, or cannot use the nasal spray treatment. * Participants with comorbid Malignancy or with a history of malignancy. * Participants with active or uncontrolled systemic autoimmune disease. * Insufficient function of key organs. * Other reasons considered by the investigator to be unsuitable for the trial.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT05659602
Study Brief:
Protocol Section: NCT05659602